The phosphorylation of glucose is the first step in glycolysis. A family of hexose phosphorylating enzymes, the hexokinases, carry out this important process. This family exhibits many different catalytic properties and varying tissue and intracellular distributions. This article is mainly restricted to the yeast and mammalian hexokinases as these have been the best characterized to date.
In yeast, three forms of hexokinase exist; hexokinase P-l (also referred to as hexokinase a); hexokinase P-I1 (hexokinase b) [ 11, and glucokinase [2] . These enzymes differ from one another in their activity with various hexoses. Both hexokinase P-I and P-I1 can use a range of hexose substrates and can be distinguished from one another by their activity differences with certain substrates, notably fructose [3] . They differ in their electrophoretic mobility and are serologically distinct 111. Yeast glucokinase, on the other hand, shows a rather narrow substrate preference, activities being highest with glucose and mannose [2] .
Both yeast hexokinase P-I and P-11 enzymes can exist as dimers, although both are readily dissociated to monomers of 50 kDa by the addition of glucose, or by raising the pH or the ionic strength 141. Yeast glucokinase appears to exist only as a monomer and has a slightly higher molecular mass ( 5 1 kDa) [2] . Hexokinase P-11 is the predominant isoenzyme in the cell. In addition to its hexose phosphorylating function, P-I1 activity is necessary for carbon catabolic repression [ 5 ] and, together with P-I, may be subject to allosteric controls [ 1, 61. Whether the glucokinase isoenzyme plays a different physiological role in the yeast cell from the other two isoenzymes is not clear.
In mammals, four isoenzymes are present: hexokinase I, 11, 111 and IV (also referred to by some authors as hexokinase A, B, C, and D, respectively). The isoenzymes can be readily separated by electrophoresis into four discrete bands [ 11. Hexokinase IV is also more commonly known as glucokinase. The molecular masses of hexokinase 1, I1 and 111 are -100 kDa as opposed to glucokinase, which has a molecular mass more like the yeast hexokinases of -50 kDa. This led to the idea that the 100 kDa molecules arose from an ancestral yeast-like gene coding for a SO kDa protein which duplicated and then fused 11.
Other major differences between hexokinases I, 11 and 111 and glucokinase exist. Glucokinase has a narrower range of hexose substrate specificity, glucose being the most physiologically relevant [7] . Several important kinetic properties distinguish the isoenzymes from one another. In general the K , values for glucose in hexokinase I, I1 and I11 are low in the range 0.1 -0.00 1 mM [ 11, whereas glucokinase has a K,,, of 5 mM. lsoenzymes I and I1 show inhibition by the product glucose 6-phosphate, which may be an important factor in the regulation of hexokinase activity [ 81. Glucokinase, however, is insensitive to glucose 6-phosphate and hexokinase 111 has a K , for glucose 6-phosphate almost ten times greater than 1 and 11 [9] . A unique feature of hexokinase 111 is that it shows inhibition of activity by high substrate concentrations, but still low enough to be physiologically relevant [9] .
The mammalian hexokinases show a wide range of tissue specificities, some tissues expressing only one isoenzyme, others a mixture. Brain and kidney have been shown to express mainly type 1 isoenzyme, skeletal muscle type 11, while fat pad, heart and intestine express about equal amounts of types 1 and I1 [lo] . Kidney, spleen and intestine also express a detectable quantity of hexokinase 111 [lo] , while the liver contains all four types [ 111. Glucokinase is expressed solely in the liver and pancreatic B-cells and may be responsible for the greatest part of glucose phosphorylation in those tissues [ 121. Whether the distinctive properties of these four types reflect different physiological functions is still a matter for debate and speculation.
Amino acid sequence comparisoris
Primary amino acid sequence studies on the hexokinases are limited, due largely to the small amounts of protein avail- T h e degree of identity observed is due not only to certain conserved regions, but occurs throughout the sequences. Insertions and deletions of a small number of residues are observable, notably between the yeast and mammalian sequences (see also [18] [19] [20] ), but for the present analysis these have been ignored and the best fit of the molecules used.
T h e yeast glucokinase molecule is the most distantly related of any of the hexokinases and interestingly is as related t o mammalian enzymes as to the other two yeast enzymes. Albig & Entian [ 171 have already noted that if one considers only the central core of about 350 amino acids o f yeast glucokinase, the similarity with the other two yeast molecules increases to about 40%. They suggest that this central core may correspond to a common ancestral protein.
T h e two yeast hexokinases have very similar sequences 115, 161, but the most conserved hexokinases appear t o bc hexokinase I enzymes from rat and human [ l o ] . T h e rat hexokinase 111 data available shows it to be closer t o hexokinase I than rat glucokinase, confirming the idea that isoenzymes 1, I1 and 111 arose from a single duplication and fusion event. Both the rat and mouse glucokinases are closer to the other mammalian enzymes than the yeast enzymes. indicating that the mammalian genes may have arisen from a common ancestor before the duplication event which gave rise to the 100 kDa hexokinases. T h e yeast glucokinase shows no greater similarity with either of the rodent glucokinases than with the other yeast or mammalian isoenzymes. so it is unlikely that the glucokinases form a separate family tree. Interestingly. the rat and the mouse glucokinases diverge rather more than thc rat and human hexokinase I molecules. Although it should be stressed that the mouse sequence is not full length, it does suggest that there may be less constraints on the high K,,, hexokinases than the low K,,, hexokinases.
A better fit of the SO kDa hexokinases to their 100 kDa counterparts was always to one-half o f the larger molecule although similarities t o the other half were always apparent. In all cases, this better fit was with the C-terminal half of the hexokinase 1, i.e. to the catalytic domain [22] . It has already been noted that the N-and C-terminal halves of both hexokinase I show about SO%, similarity between the two halves [18, 191. This confirms the idea that the 100 kDa protein arose by a duplication and fusion of an ancestral gene.
Genetic deteriniri(itiori
Three structural genes coding for the three distinct yeast isoenzymes 11, 2, 51 have been identified. T h e genetic organization of the mammalian hexokinases is much less well documented. The amino acid sequence data makes it extremely unlikely that hexokinase I, hexokinase I11 and glucokinase are coded for by the same gene. Assuming that hexokinase I1 is also different. one would predict a gene family of at least four members.
Information on genomic sequences for the mammalian genes is lacking. We have probed genomic D N A of the mouse with a partial cDNA clone t o mouse glucokinase. While not conclusive, the evidence suggests there are two genes present in the genome. Whether both are active glucokinase genes is at present unknown. Additional bands appear on the autoradiograph when less stringent washings are performed. A maximum of six bands can be observed. Given the 50% similarity between rat hexokinase I and rat glucokinase, these additional bands may correspond to the other hexokinases; their exact assignment requires further study. Comparisons were made by aligning the two sequences and looking for identical amino acid residues. The yeast isoenzymes and the rat glucokinase are -480 amino acids in length. whereas the two hexokinase I isoenzymes are -960 amino acids. The rat hexokinase I l l sequences compared were from seven tryptic pcptides. providing a total of Xh residues [ Y ] . The mouse glucokinase sequence came from a cDNA clone providing a total o f 7 I residues (R. J. Middleton & 11. G. Walker. unpublished work). The data from these partial sequences are indicated by the symbol * in the Table; hk indicates a hexokinase and gk indicates a glucokinase.
Some small deletions and insertions were necessary t o obtain the best fit between molecule\. l'hc numbers presented are the percentage exact matches of the two sequences. I n the case of the rat and human hexokinase I sequence. the results from the best half of the molecule are shown. This was invariably with the C'terminal end of the molecule (see text).
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Three-dimerisioriut striictirre stiidies utid curtrtyric sites
The three-dimensional structure of yeast hexokinase P-I1 has been determined from X-ray crystallographic studies [23-251. Each hexokinase molecule contains a deep central cleft which divides the molecule into two roughly equal lobes. From kinetic studies [26] , it was known that glucose binds to the enzyme before the ATP. Studies have shown [251 that on binding of glucose in the cleft, the smaller of the two lobes rotates 12" relative to the large lobe. This partially closes the cleft and this may bring the ATP-binding site into the active site to permit formation of the ternary complex The use of glucose analogues has identified specific residues which participate in the binding of glucose [25, 27] ; Ser-158, Asn-2 10, Asp-21 1, Glu-269 and Glu-302 have all been implicated as probable binding sites to the hydroxyl groups of glucose. These residues are present in all three yeast isoenzymes and correspond to highly conserved regions. The binding site of the adenine nucleotide has proved more difficult to locate. Affinity labelling has, however, identified a lysine residue (Lys-1 1 1 ) on the smaller lobe of hexokinase P-11 as being important [26] . This residue together with a [261.
highly conserved region of about ten residues upstream from Lys-I 11 have been put forward as a putative ATP-binding site [20] .
To date, no crystals of any mammalian hexokinase exist. Information on the three-dimensional structures is limited t o comparisons with the yeast molecule and the reactivity of particular amino acid residues. Fortunately, the yeast and mammalian primary sequences show remarkable similarities and highly conserved regions thought to be important in glucose and ATP binding can be readily assigned in rat glucokinase [20] and in the C-terminal regions of both hexokinase I isoenzymes [ 18, 191. The active residues thought to be essential for binding in yeast are present in roughly the correct positions in the other isoenzymes. Interestingly, the same putative catalytic regions can be identified in the Nterminal-half of hexokinase I [ 191. Their function in this noncatalytic region is unclear, but Schwab & Wilson [ 19) have suggested that there may be another catalytic site o n the enzyme or it may suggest sites for allosteric regulation.
Direct evidence on the active sites of the mammalian isoenzymes comes from studies of purified proteins and affinity labels, usually glucose derivatives. Reactive thiol groups have been identified at or near the glucose-binding site of rat hexokinase 11221, bovine hexokinase I [28] and rat hexokinase 11 [29] , whereas such groups are absent in rat glucokinase [30] . Considering the present sequence data available, the probable glucose-binding site in hexokinase 1 does contain cysteine residues nearby 1191, although they are unlikely to take part in any catalytic binding [28, 291. Similarly, the putative glucose-binding site of glucokinase does not contain any thiol containing residues [20] , confirming the earlier data 130).
Schwab & Wilson [ 101 have proposed a three-dimensional structure for rat hexokinase 1. They argue that taking thc strong similarities between the N-and C-terminal regions of hexokinase and between the yeast isoenzymes, hexokinase I can be represented by fusing two yeast molecules together. Their model utilizes slight modifications of the yeast molecule, but features o f the structure generated do fit existing experimental data [ 1 9 I. Present in the model are the surface positions of residues available for known proteolytic attack and a region responsible for insertion of the molecule into the mitochondria1 membrane. 
Iritrodiictiori
O u r interest in glucose phosphate isomerase (GPI; Dglucose-6-phosphate ketol isomerase, EC S.3.1.9) stems from our studies of carbohydrate metabolism in cultured animal cells. We have isolated a number of Chinese hamster cell lines affected in their ability t o utilize carbohydrates one of which is a mutant with two lesions in the glycolytic pathway.
T h e mutant ( R 1.1.7) cells were isolated as ribose-utilizing variants of the Chinese hamster ovary cell line. CHO-Kl (CCL.6 1). Subsequent work showed that thc cells wcrc essentially devoid of GPI and phosphoglyceratc kinase (PGK, E C 2.7.2.3) activities. T h e cells grow in glucosecontaining media at the same rate as the parental cells. but d o not convert glucose to lactic acid. T h e mutant cells, but not the parental cells, are rapidly killed by the application of inhibitors of respiration. Further studies established that these cells obtain their energy through the oxidation of glutamine and pyruvate which are thus essential components of the culture medium.
GIY
GPI plays an essential role in carbohydrate metabolism in all tissues, but is not usually considered to be subject to metabolic control. It does, however, stand at a major metabolic intersection, since its substrates, glucose 6-phosphate and fructose 6-phosphate are not only intermediates in glycolysis and gluconeogenesis, but also in the pentose phosphate cycle (in which GPI plays an essential role in the recycling of fructose 6-phosphate [ 1 ]), glycoprotein synthesis and inositol synthesis. Some of these roles are reflected in the physiological properties of R 1.1.7 cells which require an oxidative substrate (no glycolysis), supplementation with inositol and show changes in morphology (glycoproteins).
Deficiency of GPI activity in humans results in a rare form of non-spherocytic haemolytie anaemia of varying severity, sometimes accompanied by mild neurological impairment. It has recently been recognized that severe impairment of GPI activity can be a cause of hydrops fetalis 121.
Abbreviations used: GPI, glucose phosphate isomerase; PGK, phosphoglycerate kinax.
As indicated above, it is perhaps surprising that an enzyme with a key role in a number of metabolic pathways is apparently not subject to metabolic control nor is there any evidence for tissue-specific isoenzymes. Studies in mouse embryos show that GPI expression is activated early, and may be detected in 2.5-day-old embryos. T h e maternally and paternally derived enzymes appear to be activated synchronously and not, therefore, subject to imprinting 131. A recent report 141 on the expression of GPI in the developing chick does open up the possibility that expression is regulated in a tissue-specific fashion during development. but further work is required.
GPI has been isolated from a wide variety of sources. X-ray crystallography data and partial amino acid sequence data are available for the pig enzyme. The enzyme is a dimer of identical subunits of molecular mass 6 6 0 0 0 Da. T h e dimer contains two identical active sites which d o not interact. T h e structure has been resolved to 2.6 i\ and is o f the a//? type. Each subunit consists of two domains with the active site situated at the domain-subunit interface IS].
To study the molecular basis of the deficiency in GPI. it was necessary to develop a strategy to clone the GPI gene. Advantage was taken of the known conservation of protein sequence between glyeolytic enzymes [6] and we predicted that this conservation would extend to GPI. A mouse cDNA library (in bacteriophage Agt 10) was screened with the GPI 1 gene of Sacchuromyces cerevisiue and a recombinant, containing a 3.2 kb insert. was isolated and sequenced. At the 3' end of the insert 1.1 kb consists of approximately 0.8 kb of GP1-coding and 0.3 kb of 3' non-coding sequence. T h e 5' end of the insert consists of 2.1 k b of non-coding sequence containing a consensus sequence for a 3' splice site at the coding/non-coding sequence junction (Fig. 1 ) . T h e 2.1 kb non-coding sequence may thus be part of an intron from the mouse GPI gene, generated through reverse transcription of a splicing intermediate.
When the sequences were compared with sequences held in the Gene Bank nucleie acid database an astonishing 100% similarity was revealed between the GPI sequence (coding and 3' non-coding) and mouse neuroleukin 171. Neuroleukin Vol. 18
